Skip to Main Content


Skip Nav Destination

Health Disparities and Outcomes Research

Studies that investigate the cause and impact of differences in patient group outcomes, cancer survivorship, and the development of health policy from individual or population-level perspectives with a focus on health disparities

Latest in Health Disparities and Outcomes Research
Natalia E. Cortez, Cecilia Rodriguez Lanzi et al.
Pancreatic ductal adenocarcinoma (PDAC) continues to be a major health problem. A ketogenic diet (KD), characterized by a very low carbohydrate and high fat composition, has gained attention for its anti-tumor potential. We evaluated the effect and mechanisms of feeding a strict KD alone or in combination with gemcitabine ...
Changzhen Wang, Fahui Wang et al.
Defining a reliable geographic unit pertaining to cancer care is essential in its assessment, planning, and management. This study aims to delineate and characterize the cancer service areas (CSA) accounting for the presence of major cancer centers in the United States. We used the Medicare enrollment and claims from ...
Amber S. Kleckner, Edwin van Wijngaarden et al.
Cancer-related fatigue is a prevalent, debilitating condition, and preliminary evidence suggests a relationship between higher diet quality and lower fatigue. Serum-based carotenoids, Vitamin A, and Vitamin E are biomarkers of fruit and vegetable intake and therefore diet quality. To further elucidate the link between ...
Nora Franzen, Andreas Ziegler et al.
The high prices of innovative medicines endanger access to care worldwide. Sustainable prices need to be affordable while sufficiently incentivizing research and development (R&D) investments. A proposed solution is increased transparency. Proponents argue that price and R&D cost confidentiality are drivers of ...
John Charles A. Lacson, Scarlet H. Doyle et al.
Skin cancer incidence is increasing among Hispanics, who experience worse outcomes than non-Hispanic Whites. Precision prevention incorporating genetic testing for (melanocortin-1 receptor) MC1R, a skin cancer susceptibility marker, may improve prevention behavior.
Close Modal

or Create an Account

Close Modal
Close Modal